Clinical Trials
2 trialsNCT00541970 2018-08-17
Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
GlaxoSmithKline
Phase 1 Completed
NCT02296255 2014-11-20
Effect of HPV Vaccination on Women Aged 25 Years
Cancer Prevention and Research Institute, Italy
Phase 4 Completed